周小慧
Lv1
6 积分
2022-08-22 加入
-
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies
2天前
已完结
-
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
7天前
已完结
-
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
7天前
已完结
-
Mediastinal tumors : Diagnosis and treatment of the most common tumor entities
12天前
已完结
-
Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database
21天前
已完结
-
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
24天前
已完结
-
Assessment of the evidence yield for the calibrated PP3/BP4 computational recommendations
1个月前
已完结
-
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
1个月前
已完结
-
Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin
4个月前
已关闭
-
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
4个月前
已完结